"Drug Reduces 'Forever Chemicals' in Blood, Danish Study Finds"
A Danish study has found that the medication cholestyramine, typically used for high cholesterol, can significantly reduce "forever chemicals" (PFAS) in the blood, with a 63% decrease observed in a clinical trial. While the results are promising for treating individuals exposed to high levels of PFAS, the drug's side effects make it unsuitable for widespread and prolonged use. Researchers emphasize the need for further exploration of its impact on chronic health conditions and caution against widespread treatment due to potential risks.